Pub. Date : 2019
PMID : 31737634
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Since the 2000"s, the discovery of molecular alterations including epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements together with the development of specific tyrosine kinase inhibitors (TKIs) has facilitated the development of personalized medicine in the management of this disease. | Tyrosine | ALK receptor tyrosine kinase | Homo sapiens |